Details of the Drug Reposition

General Information of This Drug (ID: DMI57ZA)

• Drug Name: TGWOOAA (DMI57ZA)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Generalized anxiety disorder	DISPSQCW	6B00	Phase 2	[1]
Social phobia	DISQGN78	6B04	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.